- Home
- VVV vs IRTC Comparison
VVV vs IRTC Comparison
Compare VVV & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VVV
- IRTC
- Stock Information
- Founded
- VVV 1866
- IRTC 2006
- Country
- VVV United States
- IRTC United States
- Employees
- VVV N/A
- IRTC N/A
- Industry
- VVV Major Chemicals
- IRTC Medical/Dental Instruments
- Sector
- VVV Industrials
- IRTC Health Care
- Exchange
- VVV Nasdaq
- IRTC Nasdaq
- Market Cap
- VVV 4.3B
- IRTC 4.5B
- IPO Year
- VVV 2016
- IRTC 2016
- Fundamental
- Price
- VVV $37.00
- IRTC $145.74
- Analyst Decision
- VVV Buy
- IRTC Strong Buy
- Analyst Count
- VVV 12
- IRTC 10
- Target Price
- VVV $42.75
- IRTC $138.60
- AVG Volume (30 Days)
- VVV 1.9M
- IRTC 457.7K
- Earning Date
- VVV 08-06-2025
- IRTC 07-31-2025
- Dividend Yield
- VVV N/A
- IRTC N/A
- EPS Growth
- VVV 56.15
- IRTC N/A
- EPS
- VVV 2.05
- IRTC N/A
- Revenue
- VVV $1,674,400,000.00
- IRTC $618,587,000.00
- Revenue This Year
- VVV $6.67
- IRTC $19.91
- Revenue Next Year
- VVV $15.40
- IRTC $16.81
- P/E Ratio
- VVV $18.08
- IRTC N/A
- Revenue Growth
- VVV 9.56
- IRTC 20.54
- 52 Week Low
- VVV $31.02
- IRTC $55.92
- 52 Week High
- VVV $48.27
- IRTC $150.00
- Technical
- Relative Strength Index (RSI)
- VVV 59.68
- IRTC 63.44
- Support Level
- VVV $35.09
- IRTC $141.19
- Resistance Level
- VVV $37.16
- IRTC $146.90
- Average True Range (ATR)
- VVV 0.87
- IRTC 3.50
- MACD
- VVV 0.06
- IRTC -1.09
- Stochastic Oscillator
- VVV 86.16
- IRTC 63.96
About VVV Valvoline Inc.
Valvoline Inc produces, markets, and sells automotive maintenance products, particularly lubricants, to retail outlets installers, and customers. The company offers various products such as engine oil, heavy-duty engine oil, motorcycle oil, grease and brake fluid, and others. Geographically, the majority of the revenue is generated from the United States of America.
About IRTC iRhythm Technologies Inc.
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.